Shringar House of Mangalsutra: IPO Proceeds Utilization Report for Q1FY27 Filed
Shringar House of Mangalsutra Limited's Monitoring Agency Report for Q1FY27 confirms IPO proceeds utilization aligns with Offer Document disclosures. Total IPO proceeds were ₹4,009.20 million. ₹3,613.57 million allocated for working capital and general corporate purposes, with ₹395.63 million for issue expenses. No deviations or delays reported.
This is a standard quarterly compliance report. It does not contain new financial performance data or strategic announcements that would significantly impact the company's stock.
The announcement is a routine regulatory filing regarding the utilization of IPO proceeds. It confirms compliance with disclosures and no deviations, which is neutral news.
Shringar House of Mangalsutra Limited has submitted its Monitoring Agency Report for the quarter ended June 30, 2026, concerning the utilization of its Initial Public Offer (IPO) proceeds. The report, issued by CRISIL RATINGS LIMITED, confirms that the utilization of IPO funds aligns with the disclosures made in the Offer Document.
For the quarter ended June 30, 2026, the total IPO proceeds amounted to ₹4,009.20 million. Of this, ₹3,613.57 million was allocated for funding working capital requirements and general corporate purposes, and ₹395.63 million for issue expenses. As of the end of the quarter, ₹3,613.57 million had been utilized for working capital and general corporate purposes, with ₹2,800.00 million and ₹813.57 million respectively, fully utilized by the quarter ended December 31, 2025. The utilization towards issue expenses stood at ₹393.09 million, with ₹2.54 million remaining unutilized and transferred to another account for operational ease, earmarked for issue expenses.
The company reported no deviation from the stated objects of the issue. The report also confirms that shareholder approval was not required for material deviations as none occurred. There were no changes in the means of finance or major deviations observed compared to earlier monitoring agency reports. All necessary government/statutory approvals related to the object(s) have been obtained. The company declared no delays in the implementation of the objects of the issue.
The Audit Committee reviewed the statement on August 12, 2026. This intimation is also available on the company's website.
What to do with a filing like this
Shringar House of Mangalsutra Limited filed this with the NSE as a statutory disclosure, categorised under other regulatory filings. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Shringar House of Mangalsutra Limited. Read the original for the full detail.